M. Poudenx
Papers
1
Total Citations
17
H-Index
1
About
Dr. M. Poudenx is a leading figure in radiation oncology, with a focused expertise in the stereotactic body radiation therapy (SBRT) of lung cancers, particularly using the CyberKnife® system. Their seminal 2008 work, "Analyse de la toxicité précoce des traitements par Cyberknife® des cancers pulmonaires et résultats préliminaires," which has garnered 17 citations, provides a foundational analysis of early treatment toxicity and preliminary outcomes. This contribution is pivotal for understanding the safety profile and efficacy of high-precision, non-invasive radiation delivery for pulmonary malignancies. Dr. Poudenx’s research has significantly advanced clinical protocols by quantifying acute adverse effects and establishing benchmarks for patient selection and dose optimization. Their work remains a key reference for clinicians and researchers aiming to minimize radiation-induced damage while maximizing tumor control, underscoring their lasting impact on the field of thoracic oncology and stereotactic radiosurgery.
Research Focus
Key Achievements
Top Papers
- 1